DUBLIN–(BUSINESS WIRE)–The “Fundus Camera Market Share by Product Type (Mydriatic, Non-Mydriatic, Hybrid, ROP), End-Users (Ophthalmic & Optometrist Offices, Ophthalmology Clinics, Hospitals), Regions, and Companies” report has been added to Resea…
Author: Business Wire
Kubota Vision Announces Submission of Novel VAP-1 Inhibitors to the NCI Developmental Therapeutics Program for Screening in Cancer Cell Lines
SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the submission of novel Vascular Adhe…
Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases
SOUTH SAN FRANCISCO, Calif. & LEXINGTON, Mass.–(BUSINESS WIRE)–Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases
NextGen Healthcare Client Bridges Health Partners Achieves Medicare Shared Savings of Nearly $20 Million
IRVINE, Calif.–(BUSINESS WIRE)—- $NXGN #AmbulatoryHealthcare–Leveraging NextGen® Population Health Solutions, Clinically Integrated Network Improves Quality of Patient Care While Exceeding Its Savings Objectives
Katena Products Announces Steve Blazejewski as New CEO
PARSIPPANY, N.J.–(BUSINESS WIRE)–Katena Products (“Katena”), a leading provider of ophthalmic instruments, biologics, and devices, is pleased to announce that Steve Blazejewski has joined as Chief Executive Officer. As a seasoned executive, Steve bri…
Global Retinal Surgery Devices Market (2020 to 2025) – Industry Trends, Share, Size, Growth, Opportunity and Forecast – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Surgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering. The global retinal surgery devices market is curr…
Global Corneal Endothelial Dystrophy (CED) Epidemiology Forecast Report 2017-2020 & 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Corneal Endothelial Dystrophy (CED) – Epidemiology Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Corneal Endothelial Dystrophy (CED) – Epidemiology Forecast – 2030’ report delivers an i…
Ophthalmic Lens Market by Product and by Geography – Global Forecast to 2024 | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOphthalmicLensMarket–The Ophthalmic Lens Market will grow by USD 3.21 bn during 2020-2024
Optical Coherence Tomography for Ophthalmology Market by Product, End-users, & Geography (2020-2024) – Technavio
LONDON–(BUSINESS WIRE)– #GlobalOpticalCoherenceTomographyforOphthalmologyMarket–The Optical Coherence Tomography for Ophthalmology Market will grow by USD 302.3 mn during 2020-2024
Global Infrared Aspheric Optics Market Insights (2020 to 2025) – Analysis and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Infrared Aspheric Optics Global Market Insights 2020, Analysis and Forecast to 2025, by Manufacturers, Regions, Technology, Application” report has been added to ResearchAndMarkets.com’s offering. This report describes the…
Luna Innovations Acquires OptaSense
ROANOKE, Va.–(BUSINESS WIRE)– #acquisition–Luna announces acquisition of OptaSense. The combination is expected to create the world’s largest fiber optic sensing company.
CMS Confirms Continued Separate Payment for Omeros’ FDA-Approved OMIDRIA® in Ambulatory Surgery Centers
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER) announced today that the Centers for Medicare & Medicaid Services (CMS) confirmed separate payment in ambulatory surgery centers (ASCs) for Omeros’ cataract surgery drug OMIDRIA® (phenylep…
Eyenovia Announces FDA Acceptance of IND for MicroLine for Presbyopia, Clearing Path to Initiate Phase 3 VISION Trial by Year End
NEW YORK–(BUSINESS WIRE)– #Eyenovia–Eyenovia obtains FDA acceptance of its IND application for MicroLine, a therapy designed for improvement in near vision in patients with presbyopia.
APAC Dry Eye Product Industry to 2027 – Adoption in Stem Cell Therapy Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asia Pacific Dry Eye Product Market to 2027- Covid-19 Impact and Regional Analysis by product ( Artificial tears, Antibiotic Drops, Hormone Drops and Others); Type (OTC Drugs, Prescription Drugs);and Country.” report has b…
4D Molecular Therapeutics Strengthens Leadership Team with Key Appointments in Clinical Research and Development
EMERYVILLE, Calif.–(BUSINESS WIRE)–4D Molecular Therapeutics (4DMT), a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced that Robert Fishman, M.D. has joined as Chief Medical Officer…
Insights on the Ophthalmic Femtosecond Lasers Global Market to 2024 – Increasing incidence of cataracts is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Femtosecond Lasers Market 2020-2024” report has been added to ResearchAndMarkets.com’s offering. The publisher has been monitoring the ophthalmic femtosecond lasers market and it is poised to grow by $170…
Midwest Vision Partners Announces Partnership With Medina Vision Centre, Inc.
CHICAGO & MEDINA, Ohio–(BUSINESS WIRE)–Midwest Vision Partners Announces Partnership With Medina Vision Centre, Inc.
Gyroscope Therapeutics Announces Appointments of Industry Veterans in Gene Therapy, Ophthalmology and Biopharmaceuticals to Its Board of Directors
LONDON–(BUSINESS WIRE)– #GeneTherapy–Gyroscope Therapeutics Announces Appointments of Industry Veterans in Gene Therapy, Ophthalmology and Biopharmaceuticals to its Board of Directors.
Zenni Launches Signature Eyewear Collection with George and Claire Kittle
NOVATO, Calif.–(BUSINESS WIRE)– #JustGotMyZennis–George Kittle and Zenni release signature eyewear collection, designed by the San Francisco 49ers Tight End and his wife
Oxford Finance Closes $60 Million Credit Facility with RxSight
ALEXANDRIA, Va. & ALISO VIEJO, Calif.–(BUSINESS WIRE)–Oxford Finance Closes $60 Million Credit Facility with RxSight